1. Home
  2. ITRM vs KUKE Comparison

ITRM vs KUKE Comparison

Compare ITRM & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • KUKE
  • Stock Information
  • Founded
  • ITRM 2015
  • KUKE 2002
  • Country
  • ITRM Ireland
  • KUKE China
  • Employees
  • ITRM N/A
  • KUKE N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • KUKE Other Consumer Services
  • Sector
  • ITRM Health Care
  • KUKE Real Estate
  • Exchange
  • ITRM Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • ITRM 40.0M
  • KUKE 42.0M
  • IPO Year
  • ITRM 2018
  • KUKE 2021
  • Fundamental
  • Price
  • ITRM $0.73
  • KUKE N/A
  • Analyst Decision
  • ITRM Strong Buy
  • KUKE
  • Analyst Count
  • ITRM 1
  • KUKE 0
  • Target Price
  • ITRM $9.00
  • KUKE N/A
  • AVG Volume (30 Days)
  • ITRM 821.8K
  • KUKE 979.1K
  • Earning Date
  • ITRM 11-13-2025
  • KUKE 10-24-2025
  • Dividend Yield
  • ITRM N/A
  • KUKE N/A
  • EPS Growth
  • ITRM N/A
  • KUKE N/A
  • EPS
  • ITRM N/A
  • KUKE N/A
  • Revenue
  • ITRM N/A
  • KUKE $9,442,397.00
  • Revenue This Year
  • ITRM N/A
  • KUKE N/A
  • Revenue Next Year
  • ITRM $482.25
  • KUKE N/A
  • P/E Ratio
  • ITRM N/A
  • KUKE N/A
  • Revenue Growth
  • ITRM N/A
  • KUKE N/A
  • 52 Week Low
  • ITRM $0.61
  • KUKE $0.52
  • 52 Week High
  • ITRM $3.02
  • KUKE $10.00
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 50.74
  • KUKE 25.82
  • Support Level
  • ITRM $0.66
  • KUKE $0.55
  • Resistance Level
  • ITRM $0.83
  • KUKE $0.63
  • Average True Range (ATR)
  • ITRM 0.05
  • KUKE 0.07
  • MACD
  • ITRM 0.01
  • KUKE 0.02
  • Stochastic Oscillator
  • ITRM 41.24
  • KUKE 13.56

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: